Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.
Level 4 - case-series / case-control
Postmortem case-control tissue comparative study
PubMed 14502663 · doi:10.1002/mds.10486
What was done
Investigators measured reduced glutathione (GSH) and uric acid levels in postmortem substantia nigra and extra-nigral brain regions from deceased patients with idiopathic Parkinson's disease (PD), progressive supranuclear palsy (PSP), multiple system atrophy (MSA), and control brains.
What was found
Compared to controls, nigral GSH levels were significantly reduced in PD (-30%, P < 0.05) and PSP (-21%, P < 0.05). A reduction in MSA did not reach statistical significance (-20%, P = 0.078). GSH levels remained normal in all examined extra-nigral brain regions in PSP and MSA. A non-significant trend toward decreased uric acid was observed in the substantia nigra across all disease groups (-19% to -30%).
Why it matters
Glutathione depletion in the substantia nigra has long been cited as specific evidence for oxidative stress in idiopathic Parkinson's disease etiology. Finding similar deficits in PSP suggests nigral glutathione reduction is a shared feature of nigrostriatal degeneration rather than a unique primary driver of PD.
Limits
The abstract does not state the sample sizes for any of the patient or control groups. As a cross-sectional postmortem study, it cannot determine whether glutathione loss causes nigral cell death or is an end-stage consequence of degeneration. The reduction in MSA failed to reach statistical significance.
Cited by
- supports Parkinson's disease is characterized by a deficiency of the antioxidant glutathione in specific regions of the brain.